China Resources Pharmaceutical Group Ltd
3320.HK- Latest Trade
- trading lower5.33HKD
- Change
- -0.03
- % Change
0.56%Negative
- Day Range
- 5.22 - 5.45
- 52-Week Range
- 3.18 - 5.58
As of Jul 3 2022. Values delayed up to 15 minutes
- Previous Close
- 5.36
- Open
- 5.22
- Volume
- 19,701,321.00
- 3 Month Average Trading Volume
- 251.30
- Shares Out (Mil)
- 6,282.51
- Market Cap
- 33,485.78
- Forward P/E
- 7.89
- Dividend Yield
- 2.81
Key Statistics
1.85714286 mean rating - 7 analysts
- P/E Excl. Extra Items (TTM)
- 8.88
- Price To Sales (TTM)
- 0.14
- Price To Book (Quarterly)
- 0.66
- Price To Cash Flow (Per Share TTM)
- 3.54
- Total Debt/Total Equity (Quarterly)
- 110.92
- Long Term Debt/Equity (Quarterly)
- 15.91
- Return On Investment (TTM)
- 11.42
- Return On Equity (TTM)
- 2.90
2021 (millions USD)
About China Resources Pharmaceutical Group Ltd
Company Information
CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED is a Hongkong-based investment holding company. The Company, along with its subsidiaries, is principally engaged in the research and development, manufacturing, distribution and retail of pharmaceutical and other healthcare products. The Company mainly operates through three segments. Pharmaceutical Manufacturing segment is engaged in the research and development, manufacturing and sale of pharmaceutical and other healthcare products. Pharmaceutical Distribution segment is engaged in the provision of distribution solutions to pharmaceutical manufacturers and dispensers, such as hospitals and other medical institutions, distributors and retail pharmacies. Pharmaceutical Retail segment is involved in the operation of retail pharmacies in China and Hongkong.
Address
Room 4104-05, 41F,China Resources Buldng No. 26, Harbour Road, Wan Chainull,
null
Hong Kong
Industry
Major Drugs
Executive Leadership
- Yuewei Han
- Non-Executive Chairman of the Board
- Xiaosong Bai
- Chief Executive Officer, Executive Director
- Jingwen Weng
- Chief Financial Officer, Vice President, Executive Director
- Yi Feng
- Chairman of CR Double-Crane
- Dengfeng Gao
- Vice secretary and the President of Dong-E-E-Jiao
- Xiaoqing Lu
- Chairman of CR Jiangzhong
- Hong Mu
- Chairman of CR Pharmaceutical Commercial
- Huawei Qiu
- Chairman of CR Sanjiu
- Jun Wu
- Senior Vice President
- Ran Tao
- Vice President, Executive Director
- Xingpin Cui
- Vice President
- Qingsheng Meng
- Vice President
- Na Tang
- Vice President
- Yaoming Liu
- Secretary of the CPC Discipline Committee
- Chi Lik Lo
- Company Secretary
- Bo Hou
- Non-Executive Director
- Ruifang Jiao
- Non-Executive Director
- Guolong Lin
- Non-Executive Director
- Ying Tan
- Non-Executive Director
- Tingmei Fu
- Independent Non-Executive Director
- Kin Fun Kwok
- Independent Non-Executive Director
- Mo Han Shing
- Independent Non-Executive Director
- Kejian Zhang
- Independent Non-Executive Director
Latest News
Markets Performance
Official Data PartnerCommodities
| Future | Last | % Change |
|---|---|---|
| Gold | 1,806.10 | 0.11%Positive |
| Copper | 679.40 | 2.12%Negative |
| Brent Crude Oil | 111.63 | -- |
| CBOT Soybeans | 1,622.00 | 3.16%Negative |
Stocks
| Index | Last | % Change |
|---|---|---|
| S&P 500 | 3,825.33 | 1.06%Positive |
| Euro STOXX 50 | 3,448.31 | 0.19%Negative |
| FTSE 100 | 7,168.65 | 0.01%Negative |
| Nikkei 225 | 25,935.62 | 1.73%Negative |
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes